Nature's Sunshine Products, Inc. - Common Stock (NATR)
14.35
+0.11 (0.77%)
Nature's Sunshine Products is a company that specializes in the development and distribution of herbal and nutritional supplements
With a commitment to promoting health and wellness, the company offers a wide range of products, including vitamins, minerals, and herbal formulations. Nature's Sunshine focuses on using high-quality ingredients and adheres to strict manufacturing standards to ensure the efficacy and safety of its offerings. The company markets its products through a network of independent distributors, fostering a community of wellness advocates who educate consumers about the benefits of natural health solutions.
Nature's Sunshine currently trades at $14.37 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 16.9% gain during that period.
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs,
but the sector has bucked this trend lately as its six-month return of 6.9% has closely followed the S&P 500.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Inter Parfums (NASDAQIPAR) and the rest of the personal care stocks fared in Q3.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how The Honest Company (NASDAQHNST) and the rest of the personal care stocks fared in Q3.
Let’s dig into the relative performance of Nature's Sunshine (NASDAQNATR) and its peers as we unravel the now-completed Q3 personal care earnings season.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Medifast (NYSEMED).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Coty (NYSECOTY).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Estée Lauder (NYSEEL).
Wellness products company Nature’s Sunshine Products (NASDAQNATR) reported Q3 CY2024 results beating Wall Street’s revenue expectations, with sales up 3.1% year on year to $114.6 million. The company’s full-year revenue guidance of $445.5 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $0.23 per share was also 64.3% above analysts’ consensus estimates.
Wellness products company Nature’s Sunshine Products (NASDAQNATR)
will be reporting earnings tomorrow after market hours. Here’s what investors should know.
Analyst Susan Anderson projects Nature's Sunshine Products to achieve a 15% adjusted EBITDA margin by FY28, driven by digital growth, international expansion, and innovation.
LEHI, Utah, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company offering high-quality herbal and nutritional products, is confirmed to present at the 2024 Annual Gateway Conference, which is being held September 4th and 5th at the Four Seasons Hotel in San Francisco, CA.
NATR stock results show that Natures Sunshine Products missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
NATR stock results show that Natures Sunshine Products missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
LEHI, Utah, April 29, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company of premium-quality herbal and nutritional products, received six Stevies—including three Gold Stevie Awards—in the 2024 American Business Awards.
Shares of Clover Health Investments, Corp. (NASDAQCLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
